Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
August 2025
|
| In: |
HemaSphere
Year: 2025, Volume: 9, Issue: 8, Pages: 1-5 |
| ISSN: | 2572-9241 |
| DOI: | 10.1002/hem3.70190 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/hem3.70190 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/hem3.70190 |
| Author Notes: | Paul J. Bröckelmann, Boris Böll, Daniel Molin, Gundolf Schneider, Sirpa Leppä, Julia Meissner, Peter Kamper, Martin Hutchings, Jacob H. Christensen, Ulf Schnetzke, Michael Fuchs, Janina Jablonski, Dennis A. Eichenauer, Bastian von Tresckow, Wolfram Klapper, Carsten Kobe, Peter Borchmann, Alexander Fosså |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1949860442 | ||
| 003 | DE-627 | ||
| 005 | 20260121102214.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260121s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/hem3.70190 |2 doi | |
| 035 | |a (DE-627)1949860442 | ||
| 035 | |a (DE-599)KXP1949860442 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bröckelmann, Paul Jan |d 1987- |e VerfasserIn |0 (DE-588)1103596209 |0 (DE-627)861402138 |0 (DE-576)470697962 |4 aut | |
| 245 | 1 | 0 | |a Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients |c Paul J. Bröckelmann, Boris Böll, Daniel Molin, Gundolf Schneider, Sirpa Leppä, Julia Meissner, Peter Kamper, Martin Hutchings, Jacob H. Christensen, Ulf Schnetzke, Michael Fuchs, Janina Jablonski, Dennis A. Eichenauer, Bastian von Tresckow, Wolfram Klapper, Carsten Kobe, Peter Borchmann, Alexander Fosså |
| 264 | 1 | |c August 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Zuerst veröffentlicht: 18. August 2025 | ||
| 500 | |a Gesehen am 21.01.2026 | ||
| 700 | 1 | |a Böll, Boris |e VerfasserIn |4 aut | |
| 700 | 1 | |a Molin, Daniel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schneider, Gundolf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Leppä, Sirpa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Meißner, Julia |e VerfasserIn |0 (DE-588)1236765966 |0 (DE-627)176254850X |4 aut | |
| 700 | 1 | |a Kamper, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hutchings, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Christensen, Jacob H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schnetzke, Ulf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fuchs, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jablonski, Janina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eichenauer, Dennis A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a von Tresckow, Bastian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klapper, Wolfram |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kobe, Carsten |e VerfasserIn |4 aut | |
| 700 | 1 | |a Borchmann, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fosså, Alexander |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t HemaSphere |d Hoboken : John Wiley & Sons Ltd., 2017 |g 9(2025), 8 vom: Aug., Artikel-ID e70190, Seite 1-5 |h Online-Ressource |w (DE-627)1015324924 |w (DE-600)2922183-3 |w (DE-576)500571066 |x 2572-9241 |7 nnas |a Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients |
| 773 | 1 | 8 | |g volume:9 |g year:2025 |g number:8 |g month:08 |g elocationid:e70190 |g pages:1-5 |g extent:5 |a Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients |
| 856 | 4 | 0 | |u https://doi.org/10.1002/hem3.70190 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/hem3.70190 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260121 | ||
| 993 | |a Editorial | ||
| 994 | |a 2025 | ||
| 998 | |g 1236765966 |a Meißner, Julia |m 1236765966:Meißner, Julia |d 910000 |d 910100 |e 910000PM1236765966 |e 910100PM1236765966 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 999 | |a KXP-PPN1949860442 |e 4855574228 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"corporate":[{"display":"European Hematology Association","role":"isb","roleDisplay":"Herausgebendes Organ"}],"pubHistory":["Volume 1, issue 1 (December 2017)-"],"recId":"1015324924","note":["Gesehen am 18.01.2024"],"disp":"Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patientsHemaSphere","id":{"zdb":["2922183-3"],"eki":["1015324924"],"issn":["2572-9241"]},"title":[{"title":"HemaSphere","title_sort":"HemaSphere","subtitle":"open access journal of the European Hematology Association"}],"part":{"extent":"5","year":"2025","pages":"1-5","text":"9(2025), 8 vom: Aug., Artikel-ID e70190, Seite 1-5","volume":"9","issue":"8"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisher":"John Wiley & Sons Ltd. ; Wolters Kluwer Health","dateIssuedKey":"2024","publisherPlace":"Hoboken ; [Philadelphia, Pennsylvania]","dateIssuedDisp":"2024-"}]}],"name":{"displayForm":["Paul J. Bröckelmann, Boris Böll, Daniel Molin, Gundolf Schneider, Sirpa Leppä, Julia Meissner, Peter Kamper, Martin Hutchings, Jacob H. Christensen, Ulf Schnetzke, Michael Fuchs, Janina Jablonski, Dennis A. Eichenauer, Bastian von Tresckow, Wolfram Klapper, Carsten Kobe, Peter Borchmann, Alexander Fosså"]},"person":[{"given":"Paul Jan","role":"aut","display":"Bröckelmann, Paul Jan","roleDisplay":"VerfasserIn","family":"Bröckelmann"},{"given":"Boris","role":"aut","display":"Böll, Boris","roleDisplay":"VerfasserIn","family":"Böll"},{"role":"aut","display":"Molin, Daniel","given":"Daniel","family":"Molin","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Schneider","given":"Gundolf","role":"aut","display":"Schneider, Gundolf"},{"display":"Leppä, Sirpa","role":"aut","given":"Sirpa","roleDisplay":"VerfasserIn","family":"Leppä"},{"family":"Meißner","roleDisplay":"VerfasserIn","given":"Julia","role":"aut","display":"Meißner, Julia"},{"role":"aut","display":"Kamper, Peter","given":"Peter","family":"Kamper","roleDisplay":"VerfasserIn"},{"given":"Martin","role":"aut","display":"Hutchings, Martin","roleDisplay":"VerfasserIn","family":"Hutchings"},{"roleDisplay":"VerfasserIn","family":"Christensen","display":"Christensen, Jacob H.","role":"aut","given":"Jacob H."},{"family":"Schnetzke","roleDisplay":"VerfasserIn","display":"Schnetzke, Ulf","role":"aut","given":"Ulf"},{"family":"Fuchs","roleDisplay":"VerfasserIn","given":"Michael","role":"aut","display":"Fuchs, Michael"},{"given":"Janina","role":"aut","display":"Jablonski, Janina","family":"Jablonski","roleDisplay":"VerfasserIn"},{"family":"Eichenauer","roleDisplay":"VerfasserIn","given":"Dennis A.","role":"aut","display":"Eichenauer, Dennis A."},{"roleDisplay":"VerfasserIn","family":"von Tresckow","given":"Bastian","display":"von Tresckow, Bastian","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Klapper","given":"Wolfram","role":"aut","display":"Klapper, Wolfram"},{"family":"Kobe","roleDisplay":"VerfasserIn","role":"aut","display":"Kobe, Carsten","given":"Carsten"},{"family":"Borchmann","roleDisplay":"VerfasserIn","given":"Peter","role":"aut","display":"Borchmann, Peter"},{"given":"Alexander","role":"aut","display":"Fosså, Alexander","family":"Fosså","roleDisplay":"VerfasserIn"}],"physDesc":[{"extent":"5 S.","noteIll":"Illustrationen"}],"language":["eng"],"origin":[{"dateIssuedDisp":"August 2025","dateIssuedKey":"2025"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Zuerst veröffentlicht: 18. August 2025","Gesehen am 21.01.2026"],"id":{"doi":["10.1002/hem3.70190"],"eki":["1949860442"]},"title":[{"title":"Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients","title_sort":"Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients"}],"recId":"1949860442"} | ||
| SRT | |a BROECKELMABRENTUXIMA2025 | ||